Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1990 1
1997 3
2001 1
2004 1
2005 3
2006 3
2008 1
2009 1
2010 3
2011 2
2013 4
2014 5
2015 2
2016 1
2018 3
2019 3
2020 1
2022 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
Characterization of muscle strength and mobility in oculopharyngeal muscular dystrophy.
Brisson JD, Brais B, Mathieu J, Lessard I, Gagné-Ouellet V, Côté I, Gagnon C. Brisson JD, et al. Muscle Nerve. 2023 Nov;68(6):841-849. doi: 10.1002/mus.27984. Epub 2023 Oct 17. Muscle Nerve. 2023. PMID: 37849345
INTRODUCTION/AIMS: Muscle weakness, and its association with mobility limitations, has received little study in oculopharyngeal muscular dystrophy (OPMD) using quantitative and standardized assessments. ...In addition to helping health professionals to offer …
INTRODUCTION/AIMS: Muscle weakness, and its association with mobility limitations, has received little study in oculopharyngeal mu …
Severe Ocular Complications After Blepharoptosis Correction in the Oculopharyngeal Muscular Dystrophy Patient: Literature Review and Case Presentation.
Lin TY, Chen AD, Chang CH, Liang WC, Minami N, Nishino I, Lai CS. Lin TY, et al. Ann Plast Surg. 2020 Jan;84(1S Suppl 1):S84-S88. doi: 10.1097/SAP.0000000000002198. Ann Plast Surg. 2020. PMID: 31833892 Review.
BACKGROUND: Blepharoptosis correction in oculopharyngeal muscular dystrophy (OPMD) patients may result in severe ocular complications owing to lagophthalmos and ophthalmoplegia. ...METHODS: A review of the literature for severe chemosis, keratopathy, and corn …
BACKGROUND: Blepharoptosis correction in oculopharyngeal muscular dystrophy (OPMD) patients may result in severe ocular …
Muscle MRI in a large cohort of patients with oculopharyngeal muscular dystrophy.
Alonso-Jimenez A, Kroon RHMJM, Alejaldre-Monforte A, Nuñez-Peralta C, Horlings CGC, van Engelen BGM, Olivé M, González L, Verges-Gil E, Paradas C, Márquez C, Garibaldi M, Gallano P, Rodriguez MJ, Gonzalez-Quereda L, Dominguez Gonzalez C, Vissing J, Fornander F, Eisum AV, García-Sobrino T, Pardo J, García-Figueiras R, Muelas N, Vilchez JJ, Kapetanovic S, Tasca G, Monforte M, Ricci E, Gomez MT, Bevilacqua JA, Diaz-Jara J, Zamorano II, Carlier RY, Laforet P, Pelayo-Negro A, Ramos-Fransi A, Martínez A, Marini-Bettolo C, Straub V, Gutiérrez G, Stojkovic T, Martín MA, Morís G, Fernández-Torrón R, Lopez De Munaín A, Cortes-Vicente E, Querol L, Rojas-García R, Illa I, Diaz-Manera J. Alonso-Jimenez A, et al. J Neurol Neurosurg Psychiatry. 2019 May;90(5):576-585. doi: 10.1136/jnnp-2018-319578. Epub 2018 Dec 8. J Neurol Neurosurg Psychiatry. 2019. PMID: 30530568
BACKGROUND AND OBJECTIVE: Oculopharyngeal muscular dystrophy (OPMD) is a genetic disorder caused by an abnormal expansion of GCN triplets within the PABPN1 gene. ...The information generated by this study is of high diagnostic value and important for clini …
BACKGROUND AND OBJECTIVE: Oculopharyngeal muscular dystrophy (OPMD) is a genetic disorder caused by an abnormal expansi …
Botulinum toxin treatment improves dysphagia in patients with oculopharyngeal muscular dystrophy and sporadic inclusion body myositis.
Witting N, Daugaard D, Prytz S, Biernat H, Diederichsen LP, Vissing J. Witting N, et al. J Neurol. 2022 Aug;269(8):4154-4160. doi: 10.1007/s00415-022-11028-8. Epub 2022 Mar 4. J Neurol. 2022. PMID: 35244767
OBJECTIVE: Dysphagia can be troublesome in sporadic inclusion body myositis (sIBM) and oculopharyngeal muscular dystrophy (OPMD), but no established treatment exists. ...Two of 13 patients experienced a temporary worsening not reflected in dysphagia score. Li …
OBJECTIVE: Dysphagia can be troublesome in sporadic inclusion body myositis (sIBM) and oculopharyngeal muscular dystrophy …
Myoblast transfer therapy: is there any light at the end of the tunnel?
Mouly V, Aamiri A, Périé S, Mamchaoui K, Barani A, Bigot A, Bouazza B, François V, Furling D, Jacquemin V, Negroni E, Riederer I, Vignaud A, St Guily JL, Butler-Browne GS. Mouly V, et al. Acta Myol. 2005 Oct;24(2):128-33. Acta Myol. 2005. PMID: 16550930 Review.
The clinical benefits obtained from these trials were minimal, if any, and research programs concentrated then on the various pitfalls that hampered these clinical trials, leading to numerous failures. ...This resulted in a clinical trial for the phary …
The clinical benefits obtained from these trials were minimal, if any, and research programs concentrated then on the various pitfall …
Safety of botulinum toxin for dysphagia in oculopharyngeal muscular dystrophy.
Youssof S, Schrader RM, Romero-Clark C, Roy G, Spafford M. Youssof S, et al. Muscle Nerve. 2014 Apr;49(4):601-3. doi: 10.1002/mus.24123. Epub 2014 Feb 25. Muscle Nerve. 2014. PMID: 24259282 Free PMC article.
We examined the safety of cricopharyngeal BTX for dysphagia in oculopharyngeal muscular dystrophy (OPMD). METHODS: We reviewed records of patients with OPMD who received cricopharyngeal BTX. ...
We examined the safety of cricopharyngeal BTX for dysphagia in oculopharyngeal muscular dystrophy (OPMD). METHODS: We r …
Oculopharyngeal muscular dystrophy: potential therapies for an aggregate-associated disorder.
Davies JE, Berger Z, Rubinsztein DC. Davies JE, et al. Int J Biochem Cell Biol. 2006;38(9):1457-62. doi: 10.1016/j.biocel.2006.01.016. Epub 2006 Feb 28. Int J Biochem Cell Biol. 2006. PMID: 16530457 Review.
Oculopharyngeal muscular dystrophy (OPMD) is a late-onset, autosomal dominant disease caused by the abnormal expansion of a polyalanine tract within the coding region of poly(A) binding protein nuclear 1 (PABPN1). ...Recently generated animal models of OPMD w …
Oculopharyngeal muscular dystrophy (OPMD) is a late-onset, autosomal dominant disease caused by the abnormal expansion …
The role of apoptosis in neuromuscular diseases and prospects for anti-apoptosis therapy.
Miller JB, Girgenrath M. Miller JB, et al. Trends Mol Med. 2006 Jun;12(6):279-86. doi: 10.1016/j.molmed.2006.04.003. Epub 2006 May 2. Trends Mol Med. 2006. PMID: 16650805 Review.
Recent studies have confirmed this possibility by showing that pathology in mouse models of amyotrophic lateral sclerosis, congenital muscular dystrophy, oculopharyngeal muscular dystrophy and collagen-VI deficiency, but not Duchenne muscular dystrophy, is si …
Recent studies have confirmed this possibility by showing that pathology in mouse models of amyotrophic lateral sclerosis, congenital muscul …
Upper esophageal sphincter myotomy in oculopharyngeal muscular dystrophy: long-term clinical results.
Fradet G, Pouliot D, Robichaud R, St-Pierre S, Bouchard JP. Fradet G, et al. Neuromuscul Disord. 1997 Oct;7 Suppl 1:S90-5. doi: 10.1016/s0960-8966(97)00090-4. Neuromuscul Disord. 1997. PMID: 9392024 Review.
From 1980 to 1995, 53 patients with oculopharyngeal muscular dystrophy (OPMD) underwent an upper esophageal sphincter (UES) myotomy for the control of marked dysphagia. From this number, a group of 21 patients had been evaluated for preoperative and postopera …
From 1980 to 1995, 53 patients with oculopharyngeal muscular dystrophy (OPMD) underwent an upper esophageal sphincter ( …
Activation of the ubiquitin-proteasome system contributes to oculopharyngeal muscular dystrophy through muscle atrophy.
Ribot C, Soler C, Chartier A, Al Hayek S, Naït-Saïdi R, Barbezier N, Coux O, Simonelig M. Ribot C, et al. PLoS Genet. 2022 Jan 13;18(1):e1010015. doi: 10.1371/journal.pgen.1010015. eCollection 2022 Jan. PLoS Genet. 2022. PMID: 35025870 Free PMC article.
Oculopharyngeal muscular dystrophy (OPMD) is a late-onset disorder characterized by progressive weakness and degeneration of specific muscles. ...
Oculopharyngeal muscular dystrophy (OPMD) is a late-onset disorder characterized by progressive weakness and degenerati …
36 results